Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial.
Perdonà S, Di Lorenzo G, Cantiello F, Damiano R, De Sio M, Masala D, Bruni G, Gallo L, Federico P, Quattrone C, Pizzuti M, Autorino R.
Perdonà S, et al. Among authors: damiano r.
Anticancer Drugs. 2010 Jan;21(1):101-6. doi: 10.1097/CAD.0b013e3283324d83.
Anticancer Drugs. 2010.
PMID: 19858710
Clinical Trial.